Genetic background of uropathogenic Escherichia coli isolates from Slovenia in relation to fluoroquinolone and sulfamethoxazole/trimethoprim resistance-Reference-Cited by-同舟云学术

Genetic background of uropathogenic Escherichia coli isolates from Slovenia in relation to fluoroquinolone and sulfamethoxazole/trimethoprim resistance

Published:2011-12-01 Issue:2 Volume:54 Page:5-13
ISSN:1854-3073
Container-title:Acta Biologica Slovenica
language:
Short-container-title:ABS

Author:

Starčič Erjavec Marjanca,Palandačić Anja,Žgur Bertok Darja,Ambrožič Avguštin Jerneja

Abstract

A total of 99 E. coli urinary tract isolates were investigated for phylogenetic groups and 21 virulence related genes in relation to fluoroquinolone and sulfamethoxazole/trimethoprim resistance. We found that the B2 group was by far the most prevalent among susceptible isolates, while resistant isolates were more evenly distributed among groups A, B2 and D. Isolates from the B2 group exhibited the highest prevalence of virulence factors. Virulence genes hlyA, iroN and kpsMTII were statistically associated with fluoroquinolone susceptible isolates and picU with sulfamethoxazole/trimethoprim susceptible isolates. Fluoroquinolone susceptibleisolates of the phylogenetic group A were significantly associated with genes papGII, kpsMTII and iss and the susceptible group B2 isolates with genes hra in iroN. Among isolates susceptible to sulfamethoxazole/trimethoprim the presence of the hra genewas statistically significantly associated with phylogenetic group B2, while among resistant isolates, papGII was associated with phylogenetic group D.

Publisher

University of Ljubljana

Reference17 articles.

1. Car, J., Švab, I., Kersnik, J., Vegnuti, M,. 2003. Management of lower urinary tract infection in women by Slovene GPs. Fam. Pract., 20, 452–6.

2. Clermont, O., Bonacorsi. S., Bingen, E., 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol., 66, 4555–4558.

3. Clinical and Laboratory Standards Institute, 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.

4. Drews, S.J., Poutanen, S.M., Mazzulli, T., McGeer A.J., Sarabia, A., Pong-Porter, S., Rzayev, Y., Willey, B., Green, K., Low, D.E., 2005. Decreased prevalence of virulence factors among ciprofloxacinresistant uropathogenic Escherichia coli isolates. J. Clin. Microbiol., 43, 4218–20.

5. Horcajada, J.P., Soto, S., Gajewski, A., Smithson, A., Jiménez de Anta, M.T., Mensa, J., Vila, J., Johnson, J.R., 2005. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J. Clin. Microbiol.; 43: 2962–4.